2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults

By afschroeder • April 2, 2026

Shumaker AH, Bhimraj A, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Shafer RW, Tien PC, Baden LR, Cawcutt K, Chiotos K, Dzierba AL, Hardy EJ, Johnson S, Kim AY, MacBrayne C, Martin GS, Nadig N, Nakamura MM, Oliveira CR, Pearson JC, Riley L, Shoham S, Tebas P, Willis Z, Wolf J, Loveless J, Morgan RL, Falck-Ytter Y, Gandhi RT. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults. Clin Infect Dis. 2026 Apr 1:ciaf680. doi: 10.1093/cid/ciaf680. Epub ahead of print. PMID: 41920902.

Tags: covid-19, guideline, Harbor UCLA, Infectious Diseases, molnupiravir, nirmatrelvir/ritonavir, Publications, remdesivir

Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans

Goerlich K, Solis NV, Filler SG, Mitchell AP. Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans. Genetics. 2026 May 22:iyag129. doi:[...]

NATURal history of coronary PlaquE on cardiac computed tomography in individuals without MACE or lipid-lowering therapy: NATURE-CTstudy

Aldana-Bitar J, Krishnan S, Ichikawa K, Kinninger A, Hubbard L, Sallam T, Roy S, Lakshmanan S, Budoff MJ, Karlsberg RP. NATURal history of coronary PlaquE[...]

Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3-5: A randomized controlled trial protocol

Kharma JA, Sultan R, Rizk R, Haroun D, Kilani H, Kalantar-Zadeh K, Gubbels J, Bessems K. Plant-dominant low-protein diet versus standard care in adults with[...]